Dipyridamole NDC 68382-189

NDC codes

FDA NDC Directory

Product NDC (as listed)68382-189Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68382-0189Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
68382-189-01	68382018901	100 TABLET, FILM COATED in 1 BOTTLE (68382-189-01)Marketed from May 22, 2008
68382-189-05	68382018905	500 TABLET, FILM COATED in 1 BOTTLE (68382-189-05)Marketed from May 22, 2008
68382-189-10	68382018910	1000 TABLET, FILM COATED in 1 BOTTLE (68382-189-10)Marketed from May 22, 2008
68382-189-77	68382018977	10 BLISTER PACK in 1 CARTON (68382-189-77) / 10 TABLET, FILM COATED in 1 BLISTER PACKMarketed from May 22, 2008

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dipyridamole
Generic name (nonproprietary): dipyridamole
Active ingredients: Dipyridamole — 75 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Zydus Pharmaceuticals USA Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 040874
Marketing start: May 22, 2008
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Platelet Aggregation (Physiologic effect)
Identifiers: Product ID 68382-189_8b638b19-214a-4a58-a336-656d690130e3SPL ID 8b638b19-214a-4a58-a336-656d690130e3SPL set ID 004bada0-dbf7-4a94-8792-6833d7eeda2bRxCUI 197622, 309952, 309955UNII 64ALC7F90C
Pharmacologic class: Platelet Aggregation Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468382018901 followed by a unit qualifier and the quantity

Package 68382-0189-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 16, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Dipyridamole tablets are indicated as an adjunct to coumarin anticoagulants in the prevention of postoperative thromboembolic complications of cardiac valve replacement.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 040874

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 040874
Product	Strength	Form · route	Labeler	Product NDC
Dipyridamole	Dipyridamole 50 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4650
Dipyridamole	Dipyridamole 50 mg/1	Tablet, Film coatedOral	Zydus Lifesciences Limited	65841-663
Dipyridamole	Dipyridamole 25 mg/1	Tablet, Film coatedOral	Zydus Lifesciences Limited	65841-662
Dipyridamole	Dipyridamole 75 mg/1	Tablet, Film coatedOral	Zydus Lifesciences Limited	65841-664
Dipyridamole	Dipyridamole 25 mg/1	Tablet, Film coatedOral	Zydus Pharmaceuticals USA Inc.	68382-187
Dipyridamole	Dipyridamole 50 mg/1	Tablet, Film coatedOral	Zydus Pharmaceuticals USA Inc.	68382-188